3.95 USD
↘ 0.02 (0.58%)LIVE (AS OF 09:56 AM EDT)
Aquestive Therapeutics, Inc. Common Stock
AQSTNASDAQ • USD
Market: OPEN
Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $3.95. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (138.2%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.00
High?$4.06
Low?$3.95
Prev. Close?$3.97
Volume?69.9K
Avg. Volume?2.2M
VWAP?$3.99
Rel. Volume?0.03x
Bid / Ask
Bid?$3.96 × 800
Ask?$3.99 × 200
Spread?$0.03
Midpoint?$3.98
Valuation & Ratios
Market Cap?498.3M
Shares Out?125.5M
Float?107.7M
Float %?85.8%
P/E Ratio?N/A
P/B Ratio?-8.81
EPS?-$0.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
502.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?73
Short Sent.?30
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.53Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?25.63%Squeeze Risk
Short Interest?27.6M
Days to Cover?13.9
Free Float107.7M
Avg Daily Volume2.0M
Settlement Date2026-10-15
Financial Health
Current Ratio?7.19Strong
Quick Ratio?6.74Strong
Cash Ratio?5.98Strong
Debt/Equity?-0.90Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-8.81CHEAP▾
S&P97
P/S?9.21HIGH▾
Peers100
S&P9
P/FCF?N/A▾
EV/EBITDA?-8.2CHEAP▾
S&P97
EV/Sales?8.33HIGH▾
Peers100
S&P16
Returns & Efficiency
ROE?138.2%STRONG▾
Peers50
S&P97
ROA?-59.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-45949000
Enterprise Value?$450.5M
Fundamentals ratios updated end of day